EMA: New Tools to Speed Medicine Development

The European Medicines Agency (EMA) has launched three new features within its PRIME scheme to accelerate the development of medicines that address unmet medical needs. These tools provide enhanced support and interaction for developers of promising medicines. The goal is to bring innovative treatments to patients in the EU more quickly. This development aims to foster innovation and improve access to essential medicines.

Read source